morning consult poll: prescription drug prices

MORNING CONSULT

This Morning Consult poll was sponsored by the Campaign for Sustainable Rx Pricing and was

conducted from July 9-11, 2014, among a national sample of 2,010 likely 2014 voters. The

interviews were conducted online and the data were weighted to approximate a target sample of

likely voters based on age, race/ethnicity, gender, educational attainment, region, annual household

income, home ownership status and marital status. Results from the full survey have a margin of

error of plus or minus two percentage points.

POLL: PRESCRIPTION DRUG PRICES

264%

77%84% 82%

75%

35%

24%

15% 17%25%

Uninsured Employer-Based Government Plan Generic Drug Brand Name Drug

THREE OUT OF FOUR LIKLEY VOTERS ARE SATISFIED

WITH WHAT THEY PAY FOR PRESCRIPTION DRUGS

How would you describe your level of satisfaction with what you pay for

prescription drugs?

Satisfied

Not

Satisfied

By Type of Treatment Used

in the Past YearBy Insurance Status

#140701: National Coalition on Health Cares Campaign for Sustainable Rx Pricing, July 9-11, 2014, N= 2,010 likely 2014 voters

Total: 78% - 22%

Satisfied

Not

Satisfied Satisfied

Not

Satisfied Satisfied

Not

Satisfied Satisfied

Not

Satisfied

332%

4%9%

12%

38%

6%

DrugCompany

Profits

DrugAdvertising

DrugRegulation& Approval

Cost ofNew Drug

R&D

All of theAbove

Not Sure

32%

4%9%

12%

38%

A lot Somewhat A little Not Really Not at all

What do you think is most responsible for

higher prescription drug costs?

How much do you think prescription drug

prices impact insurance premiums?


LIKELY VOTERS THINK DRUG COMPANY PROFITS ARE

A KEY DRIVER IN HIGHER PRESCRIPTION DRUG

COSTS BUT ARE SPLIT ON WHETHER DRUG PRICES

IMPACT INSURANCE PREMIUMS

418%

82%

Acceptable and what we have to payfor innovative, life-saving drug

treatments

Unacceptable and jeopardizes the veryinnovation that is a hallmark of the

American health care system

Thinking more about prescription drug costs, there are certain types

of prescription drugs prescribed for complex conditions known as

specialty drugs that either very expensive and/or need to be given

by a physician or other clinician and often given in the doctors office

or other health care setting. One recent example of this is a drug

that was developed to treat hepatitis C. Some early tests indicate

that this drug when used in combination with other treatments could

in many instances cure individuals with hepatitis C, but the

company manufacturing this drug has priced the treatment at

$84,000 for a 12 week course of treatment which is $1,000 per day.

Thinking specifically about this drug, the price is:


BY A FOUR TO ONE MARGIN, LIKELY VOTERS FIND THE

PRICE OF SOLVADI UNACCEPTABLE

561%57% 59%

26%

37%32%

14%

6%10%

Uninsured Employer-based Government Plan

Thinking more about the prices for these type of

specialty drugs, how concerned are you that you

or your family wont be able to afford these types of medicines in the future should you need them.

Very Somewhat Not at all

Total: 57% - 35% - 8%

Very Somewhat Not at all Very Somewhat Not at all


NEARLY SIX OUT OF TEN LIKELY VOTERS ARE

CONCERNED ABOUT AFFORDING SPECIALTY DRUGS

IN THE FUTURE SHOULD THEY NEED THEM

631%

3% 5%

22% 20% 18%

Individuals andfamilies who purchaseinsurance on their own

Employers Employees Seniors who haveMedicare

Lower incomeindviduals who rely on

Medicaid

Taxpayers

Thinking more about the prices charged for some of these specialty

drugs, who do you think will be impacted most by these prices?


LIKELY VOTERS IDENTIFY INDIVIDUALS AND FAMILIES

AS BEING IMPACTED MOST BY HIGH SPECIALTY DRUG

PRICES

711% 12% 10%

58%

67%60%

31%

21%

29%

Uninsured Employer-based Government Plan

Do you think there is enough transparency in the

prescription drug industry when it comes to how

they price drugs?

Yes No Not Sure

Total: 12% - 64% - 25%

Yes No Not Sure Yes No Not Sure


OVER SIX IN TEN LIKLEY VOTERS THINK THERE IS NOT

ENOUGH TRANSPARENCY WHEN IT COMES TO

PRESCRIPTION DRUG PRICES

870%

68%

67%

64%

62%

62%

61%

60%

Collaborate with other manufacturers to reduce the costs of R&D

Provide more transparency to consumers about how effective the

new treatment is in relation to existing treatments

Require drug companies to disclose their actual R&D costs for a

particular drug

Provide more transparency to consumers about the cost of new

treatments versus old treatments

Cut back on expensive direct-to-consumer marketing

Commit to limit price increases for existing drugs to no more than

the rate of inflation

Publish a list of all price increases for existing products on their website so

that consumers can see how the price of drugs is increasing from year to year

Require drug companies to submit information about the value of a medicine for

example, will it reduce other health care costs and over what period of time

Below is a list of steps that could be taken to help increase transparency. Tell me on a scale of 1

to 10, 1 being a bad idea and 10 being a good idea what you think of each idea

% Rated 8-10


REDUCING THE COSTS OF R&D, PROVIDING

COMPARATIVE EFFECTIVENESS DATA, AND

DISCLOSING R&D COSTS VIEWED AS GOOD IDEAS

morning consult poll: prescription drug prices

Documents